2018
Angel-Korman A, Stern L, Sarosiek S, Sloan MJ, Doros G, Sanchorawala V, Havasi A. Long-term outcome of kidney transplantation in AL amyloidosis. Kidney International. 21 Dec 2018. doi: 10.1016/j.kint.2018.09.021. View in PubMed
McCausland KL, Quock TP, Rizio AA, Bayliss MS, White MK, Guthrie SD, Sanchorawala V. Cardiac biomarkers and health‐related quality of life in patients with light chain (AL) amyloidosis. British Journal of Haematology. 22 Nov 2018. doi:10.1111/bjh.15693. View in PubMed
Merlini G, Dispenzieri A, Sanchorawala V, Schönland SO, Palladini G, Hawkins PN, Gertz MA. Systemic immunoglobulin light chain amyloidosis. Nature Reviews Disease Primers. 4 Oct 2018, 38 (2018). doi: 10.1038/s41572-018-0034-3. View in Nature Reviews
Early Diagnosis of Cardiac Amyloidosis by Carpal Tunnel Surgery: Is it All in the Wrist? Journal of the American College of Cardiology.
MA. Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial. Amyloid. 31 Aug 2018: 1-9. doi: 10.1080/13506129.2018.1503593. View in PubMed
Benson MD, Waddington-Cruz M, Berk JL, Polydefkis M, Dyck PJ, Wang AK, Planté-Bordeneuve V, Barroso FA, Merlini G, Obici L, et al. Inotersen treatment for patients with hereditary transthyretin amyloidosis. New England Journal of Medicine 379(1), 22-31 2018 Jul 5. doi:10.1056/NEJMoa1716793. View in PubMed
Adams D, Gonzalez-Duarte A, O’Riordan WD, Yang CC, Ueda M, Kristen AV, Tournev I, Schmidt HH, Coelho T, Berk JL, et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. New England Journal of Medicine 379(1), 11-21 2018 Jul 5. doi:10.1056/NEJMoa1716153. View in PubMed
Mints YY, Doros Gheorghe, Berk JL, Connors LH & Ruberg FL. Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience. ESC Heart Failure (2018) 2018 Jun 19. doi:10.1002/ehf2.12308. View in Wiley Library
Copperman TS, Truong MT, Berk JL & Sobel RK. External beam radiation for localized periocular amyloidosis: a case series. Orbit, 37(3) 2018 Jun 11. doi:10.1080/01676830.2018.1483407. View in PubMed
White PS, Phull P, Brauneis D, Sloan JM, Quillen K, Sarosiek S & Sanchorawala V. High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers. Bone Marrow Transplantation, 2018 2018 June 8. doi:10.1038/s41409-018-0242-1. View in Springer Nature
Siddiqi OK, Sanchorawala V & Ruberg FL. Echocardiography and survival in light chain cardiac amyloidosis: back to basics. Circ Cardiovasc Imaging, 11(5) 2018 May 11. doi:. View in PubMed
Jhaveri T, Sarosiek S, Ruberg FL, Siddiqi O, Berk JL & Sanchorawala V. Once AL amyloidosis: not always AL amyloidosis. Amyloid: The Journal of Protein Folding Disorders 2018 Mar 8. doi:10.1080/13506129.2018.1449104. View in Tandfonline | As Attachment
Hanson JLS, Arvanitis M, Koch CM, Berk JL, Ruberg FL, Prokaeva T & Connors LH. Use of serum transthyretin as a prognostic indicator and predictor of outcome in cardiac amyloid disease associated with wild-type transthyretin. Circulation: Heart Failure, 11 (2) 2018 Feb 15. doi:
Havasi A, Doros G & Sanchorawala V. Predictive value of the new renal response criteria in AL amyloidosis treated with high dose melphalan and stem cell transplantation. American Journal of Hematology. 2018 Feb 12. doi
Phull P, Sanchorawala V, Connors LH, Doros G, Ruberg FL, Berk JL & Sarosiek S. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR). Amyloid: The Journal of Protein Folding Disorders. 2018 Feb 9. doi:10.1080/13506129.2018.1436048. View in Tandfonline
Parameswaran H, Huamao ML, Asche CV, Ren J, Yong C, Luptakova K, Faller DV & Sanchorawala V. Treatment patterns and health care resource utilization among patients with relapsed/refractory systemic light chain amyloidosis. Amyloid: The Journal of Protein Folding Disorders. 2018 Jan 5. doi:10.1080/13506129.2017.1411796. View in Tandfonline
Siddiqi OK, & Ruberg FL. Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment. Trends in Cardiovascular Medicine, 28 (1), 22-23 2018 January. doi:10.1016/j.tcm.2017.07.004. View in ScienceDirect